Correlation Between Nautilus Biotechnology and Genscript Biotech
Can any of the company-specific risk be diversified away by investing in both Nautilus Biotechnology and Genscript Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nautilus Biotechnology and Genscript Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nautilus Biotechnology and Genscript Biotech, you can compare the effects of market volatilities on Nautilus Biotechnology and Genscript Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nautilus Biotechnology with a short position of Genscript Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nautilus Biotechnology and Genscript Biotech.
Diversification Opportunities for Nautilus Biotechnology and Genscript Biotech
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Nautilus and Genscript is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Nautilus Biotechnology and Genscript Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genscript Biotech and Nautilus Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nautilus Biotechnology are associated (or correlated) with Genscript Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genscript Biotech has no effect on the direction of Nautilus Biotechnology i.e., Nautilus Biotechnology and Genscript Biotech go up and down completely randomly.
Pair Corralation between Nautilus Biotechnology and Genscript Biotech
Given the investment horizon of 90 days Nautilus Biotechnology is expected to generate 1.14 times more return on investment than Genscript Biotech. However, Nautilus Biotechnology is 1.14 times more volatile than Genscript Biotech. It trades about 0.04 of its potential returns per unit of risk. Genscript Biotech is currently generating about -0.01 per unit of risk. If you would invest 176.00 in Nautilus Biotechnology on August 25, 2024 and sell it today you would earn a total of 64.00 from holding Nautilus Biotechnology or generate 36.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nautilus Biotechnology vs. Genscript Biotech
Performance |
| Timeline |
| Nautilus Biotechnology |
| Genscript Biotech |
Nautilus Biotechnology and Genscript Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nautilus Biotechnology and Genscript Biotech
The main advantage of trading using opposite Nautilus Biotechnology and Genscript Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nautilus Biotechnology position performs unexpectedly, Genscript Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genscript Biotech will offset losses from the drop in Genscript Biotech's long position.| Nautilus Biotechnology vs. C4 Therapeutics | Nautilus Biotechnology vs. Kymera Therapeutics | Nautilus Biotechnology vs. Foghorn Therapeutics | Nautilus Biotechnology vs. Revolution Medicines |
| Genscript Biotech vs. Telix Pharmaceuticals Limited | Genscript Biotech vs. Keros Therapeutics | Genscript Biotech vs. Zentalis Pharmaceuticals Llc | Genscript Biotech vs. Innovent Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |